Research Desk Line-up: Matthews Intl. Post Earnings Coverage
LONDON, UK / ACCESSWIRE / November 22, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Nutrisystem, Inc. (NASDAQ: NTRI), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=NTRI, following the Company's posting of its third quarter fiscal 2017 operating results on October 25, 2017. The leading provider of weight management products and services' revenues surged 26.95% on a y-o-y basis. The Company notched a 17th consecutive quarter of y-o-y top-line growth, and also surpassed earnings and revenue expectations. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:
Get more of our free earnings reports coverage from other constituents of the Personal Services industry. Pro-TD has currently selected Matthews International Corporation (NASDAQ: MATW) for due-diligence and potential coverage as the Company announced on November 16, 2017, its financial results for the fiscal year which ended on September 30, 2017. Register for a free membership today, and be among the early birds that get access to our report on Matthews Intl. when we publish it.
At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on NTRI; also brushing on MATW. With the links below you can directly download the report of your stock of interest free of charge at:
Nutrisystem reported revenues of $158.15 million for the third quarter of the fiscal year 2017 compared to $124.57 million in Q3 FY16, an increase of 26.95% on a y-o-y basis. The Company's revenue numbers topped analysts' estimates of $155.00 million.
For Q3 FY17, Nutrisystem reported total costs and expenses of $136.81 million compared to $112.23 million in Q3 FY16, an increase of 21.90% on a y-o-y basis.
The Company's operating income amounted to $21.34 million in Q3 FY17 compared to $12.34 million in Q3 FY16, increasing 72.98% on a y-o-y basis. The Company's adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) amounted to approximately $27.70 million in Q3 FY17 compared to $18.10 million in Q3 FY16, resulting in an approximately 53.00% increase on a y-o-y basis.
Nutrisystem reported a net income of $15.03 million in Q3 FY17 compared to $7.95 million in Q3 FY16, an increase of 89.04%. The diluted earnings per share (EPS) of Nutrisystem amounted to $0.49 for the reported quarter compared to $0.27 in Q3 FY16, increasing 81.48% on a y-o-y basis. The diluted EPS of $0.50 beat analysts' estimates of $0.47.
Nutrisystem posted cash and cash equivalents of $47.65 million as on September 30, 2017, compared to $9.62 million as on December 31, 2016. Nutrisystem reported cash and cash equivalents of $47.65 million for the nine months ending September 30, 2017, compared to $27.02 million for the nine months ending September 30, 2016.
The Company posted receivables of $18.90 million in Q3 FY17 compared to $17.56 million in Q4 FY16. The inventories of Nutrisystem amounted to $23.83 million in Q3 FY17 compared to $38.50 million in Q4 FY16. The accounts payable of Nutrisystem amounted to $33.68 million in Q3 FY17 compared to $33.11 million in Q4 FY16, resulting in an increase of 1.74%.
The Company reported cash flow from operating activities of $80.95 million for the nine months ended September 30, 2017, compared to $55.92 million for the same period of the fiscal year 2016.
In Q3 FY17, the Company repurchased stocks worth $1.5 million as part of its existing share buyback program.
For Q4 FY17, Nutrisystem expects revenue to be in the range of $126.00 million - $131.00 million, and net income to be in the band of $11.40 million - $12.70 million.
The diluted EPS is expected to be in the range of $0.37 - $0.42, and adjusted EBITDA to be between $23.70 million - $25.70 million for fourth quarter of the fiscal year 2017.
For the full year FY17, the Company is expecting revenue to be in the range of $692.00 million - $697.00 million; net income to be between $58.30 million - $59.70 million; diluted EPS to be between $1.91 - $1.96; and adjusted EBITDA to be between $109.40 million - $111.40 million.
On Tuesday, November 21, 2017, the stock closed the trading session at $48.50, slightly down 0.41% from its previous closing price of $48.70. A total volume of 393.74 thousand shares have exchanged hands. Nutrisystem's stock price soared 34.72% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have skyrocketed 39.97%. The stock is trading at a PE ratio of 26.24 and has a dividend yield of 1.44%. At Tuesday's closing price, the stock's net capitalization stands at $1.45 billion.
Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charter-holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (917) 341.4653
Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Pro-Trader Daily